Notch1 contributes to an immune-suppressive tumor microenvironment by inhibiting the expression of SNAP23 and overexpression of IL-6, IL-8, and CCL5 downstream of the pathway, thus affecting the efficacy of immune-checkpoint inhibitors (47). The gene discussed is CCL5; the disease is neoplasm.